Analysis of over 10,000 cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 5, 2013, Pages 987-992

  White, Kristin L ^a   Vierkant, Robert A ^b   Fogarty, Zachary C ^b   Charbonneau, Bridget ^b   Block, Matthew S ^b   Pharoah, Paul D P ^c   Chenevix Trench, Georgia ^d   Rossing, Mary Anne ^e,f   Cramer, Daniel W ^g,h   Pearce, Celeste Leigh ⁱ   Schildkraut, Joellen M ^j,k   Menon, Usha ^l   Kjaer, Susanne Kruger ^m,n   Levine, Douglas A ^o   Gronwald, Jacek ^p   Culver, Hoda Anton ^q   Whittemore, Alice S ^r   Karlan, Beth Y ^s   Lambrechts, Diether ^t,u   Wentzensen, Nicolas ^v   Kupryjanczyk, Jolanta ^w   Chang Claude, Jenny ^x   Bandera, Elisa V ^y   Hogdall, Estrid ^n,z   Heitz, Florian ^aa,ab   Kaye, Stanley B ^ac   Fasching, Peter A ^ad,ae   Campbell, Ian ^af,ag   Goodman, Marc T ^s   Pejovic, Tanja ^ah,ai   Bean, Yukie ^ah,ai   Lurie, Galina ^aj   Eccles, Diana ^ak   Hein, Alexander ^ad   Beckmann, Matthias W ^ad   Ekici, Arif B ^al   Paul, James ^am   Brown, Robert ^an   Flanagan, James M ^an   Harter, Philipp ^aa,ab   Du Bois, Andreas ^aa,ab   Schwaab, Ira ^ao   Hogdall, Claus K ^m   Lundvall, Lene ^m   Olson, Sara H ^o   Orlow, Irene ^o   Paddock, Lisa E ^ap   Rudolph, Anja ^x   Eilber, Ursula ^x   Dansonka Mieszkowska, Agnieszka ^w   Rzepecka, Iwona K ^w   Ziolkowska Seta, Izabela ^w   Brinton, Louise ^v   Yang, Hannah ^v   Garcia Closas, Montserrat ^aq,ar   Despierre, Evelyn ^t,as   Lambrechts, Sandrina ^t,as   Vergote, Ignace ^t,as   Walsh, Christine ^s   Lester, Jenny ^s   Sieh, Weiva ^r   McGuire, Valerie ^r   Rothstein, Joseph H ^r   Ziogas, Argyrios ^q   Lubiński, Jan ^p   Cybulski, Cezary ^p   Menkiszak, Janusz ^p   Jensen, Allan ⁿ   Gayther, Simon A ⁱ   Ramus, Susan J ⁱ   Gentry Maharaj, Aleksandra ^l   Berchuck, Andrew ^k   Wu, Anna H ⁱ   Pike, Malcolm C ^i,o   Van DenBerg, David ⁱ   Terry, Kathryn L ^g,h   Vitonis, Allison F ^g   Doherty, Jennifer A ^at   Johnatty, Sharon E ^d   DeFazio, Anna ^au   Song, Honglin ^c   Tyrer, Jonathan ^c   Sellers, Thomas A ^av   Phelan, Catherine M ^av   Kalli, Kimberly R ^b   Cunningham, Julie M ^b   Fridley, Brooke L ^aw   Goode, Ellen L ^b   more..

^a Department of Medicine   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e USA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j DUKE CANCER INSTITUTE   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m University of Copenhagen   (Denmark)

ⁿ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^o MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^p POMERANIAN MEDICAL UNIVERSITY   (Poland)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s CEDARS SINAI MEDICAL CENTER   (United States)

^t UNIVERSITY OF LEUVEN   (Belgium)

^u UNIVERSITY OF LEUVEN   (Belgium)

^v NATIONAL CANCER INSTITUTE   (United States)

^w INSTITUTE OF ONCOLOGY   (Poland)

^x GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^y ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^z UNIVERSITY OF COPENHAGEN   (Denmark)

^aa DR HORST SCHMIDT KLINIKEN   (Germany)

^ab KLINIKEN ESSEN MITTE   (Germany)

^ac ROYAL MARSDEN HOSPITAL   (United Kingdom)

^ad UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^ae UNIVERSITY OF CALIFORNIA   (United States)

^af PETER MACCALLUM CANCER CENTRE   (Australia)

^ag UNIVERSITY OF MELBOURNE   (Australia)

^ah OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^ai OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^aj UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ak UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^al UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^am BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^an IMPERIAL COLLEGE LONDON   (United Kingdom)

^ao Institut Für Humangenetik Wiesbaden   (Germany)

^ap NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^aq INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ar Breakthrough Breast Cancer Research Centre   (United Kingdom)

^as UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^at DARTMOUTH MEDICAL SCHOOL   (United States)

^au UNIVERSITY OF SYDNEY   (Australia)

^av H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^aw UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C8; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; INTERLEUKIN 18; MULTIDRUG RESISTANCE PROTEIN 1; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MITOSIS; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 84877971533     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0028     Document Type: Article

References (8)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer J Clin 2011;61:69-90.
2. Bolton KL, Ganda C, Berchuck A, Pharaoh PD, Gayther SA. Role of common genetic variants in ovarian cancer susceptibility and outcome: Progress to date from the Ovarian Cancer Association Consortium (OCAC). J Intern Med 2012;271:366-78.
3. Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, et al. Inherited determinants of ovarian cancer survival. Clin Cancer Res 2010;16:995-1007.
4. Goode EL, Chenevix-Trench G, Hartmann LC, Fridley BL, Kalli KR, Vierkant RA, et al. Assessment of hepatocyte growth factor in ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 2011;20:1638-48.
5. Peethambaram P, Fridley BL, Vierkant RA, Larson MC, Kalli KR, Elliott EA, et al. Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. Int J Mol Epidemiol Genet 2011;2:185-95.
6. Pharoah PDP, Tsai YY, Ramus SJ, PhelanCM, Goode EL, Lawrenson K, et al. GWAS meta-analysis and replication identifies three novel common susceptibility loci for ovarian cancer. Nat Genet 2013;45: 362-70.
7. Chung CC, Chanock SJ. Current status of genome-wide association studies in cancer. Hum Genet 2011;130:59-78.
8. Diaz-Padilla I, Amir E, Marsh S, Liu G, Mackay H. Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: A systematic review. Gynecol Oncol 2012;124:354-65.